Fructosamine oxidase: antagonists and inhibitors
AssigneeProtemix Corporation Limited
InventorJohn Richard Baker
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating an individual with diabetes mellitus by administering to said individual an effective amount of copper chelators, hydrazine compounds, and/or substrate analogues. The invention also relates to methods of treating an individual with diabetes mellitus by lessening frictosamine odixase activity in said individual. Provided within is disclosure pertaining to treatment, pharmaceutical compositions, dosage ranges, and uses of frictosaminc oxidase enzyme inhibitors to lessen fructosamine oxidase activity.
Claims35
A method for treating an individual with diabetes mellitus comprising administering to said individual an effective amount of fructosamine oxidase inhibitor to inhibit fructosamine oxidase activity associated with the diabetic state.
A method of treating an individual with diabetes mellitus comprising administering an effective amount of copper chelator.
A method for treating an individual with diabetes mellitus comprising administering to said individual an effective amount of a combination of fructosamine oxidase inhibitors to inhibit fructosamine oxidase activity associated with the diabetic state.
Dependencies are inferred from the claim text.